A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon
NCT00498615
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Raynaud
Scleroderma
Interventions
DRUG:
Fasudil
Sponsor
Johns Hopkins University